BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 20703029)

  • 1. Mechanisms of ocular angiogenesis and its molecular mediators.
    Siemerink MJ; Augustin AJ; Schlingemann RO
    Dev Ophthalmol; 2010; 46():4-20. PubMed ID: 20703029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiostatic and angiogenic factors.
    de Groot H; Schmit-Eilenberger V; Kirchhof J; Augustin AJ
    Dev Ophthalmol; 2010; 46():1-3. PubMed ID: 20703028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEDF in angiogenic eye diseases.
    Tombran-Tink J
    Curr Mol Med; 2010 Apr; 10(3):267-78. PubMed ID: 20236057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinorganic aspects of angiogenesis.
    D'Andrea LD; Romanelli A; Di Stasi R; Pedone C
    Dalton Trans; 2010 Sep; 39(33):7625-36. PubMed ID: 20535417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for VEGF as a negative regulator of pericyte function and vessel maturation.
    Greenberg JI; Shields DJ; Barillas SG; Acevedo LM; Murphy E; Huang J; Scheppke L; Stockmann C; Johnson RS; Angle N; Cheresh DA
    Nature; 2008 Dec; 456(7223):809-13. PubMed ID: 18997771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF as a key mediator of angiogenesis in cancer.
    Carmeliet P
    Oncology; 2005; 69 Suppl 3():4-10. PubMed ID: 16301830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroblast survival depends on mature vascular network formation after mouse stroke: role of endothelial and smooth muscle progenitor cell co-administration.
    Nih LR; Deroide N; Leré-Déan C; Lerouet D; Soustrat M; Levy BI; Silvestre JS; Merkulova-Rainon T; Pocard M; Margaill I; Kubis N
    Eur J Neurosci; 2012 Apr; 35(8):1208-17. PubMed ID: 22512253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor angiogenesis of SCLC inhibited by decreased expression of FMOD via downregulating angiogenic factors of endothelial cells.
    Ao Z; Yu S; Qian P; Gao W; Guo R; Dong X; Xu J; Zhang R; Jiang C; Ji F; Qian G
    Biomed Pharmacother; 2017 Mar; 87():539-547. PubMed ID: 28081464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediators of ocular angiogenesis.
    Qazi Y; Maddula S; Ambati BK
    J Genet; 2009 Dec; 88(4):495-515. PubMed ID: 20090210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGFR2-dependent angiogenic capacity of pericyte-like dental pulp stem cells.
    Janebodin K; Zeng Y; Buranaphatthana W; Ieronimakis N; Reyes M
    J Dent Res; 2013 Jun; 92(6):524-31. PubMed ID: 23609159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MOLECULAR AND CELLULAR MECHANISMS OF ANGIOGENESIS IN PHYSIOLOGICAL AND PATHOLOGICAL CONDITIONS].
    Rubina KA; Tkachuk VA
    Ross Fiziol Zh Im I M Sechenova; 2017 Feb; 103(2):121-37. PubMed ID: 30199169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
    Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
    Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factors in retinal and choroidal neovascular diseases.
    Kinnunen K; Ylä-Herttuala S
    Ann Med; 2012 Feb; 44(1):1-17. PubMed ID: 21284527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
    Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels.
    Bauer SM; Bauer RJ; Liu ZJ; Chen H; Goldstein L; Velazquez OC
    J Vasc Surg; 2005 Apr; 41(4):699-707. PubMed ID: 15874936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells.
    Palanisamy K; Nareshkumar RN; Sivagurunathan S; Raman R; Sulochana KN; Chidambaram S
    Microvasc Res; 2019 Mar; 122():136-145. PubMed ID: 30144414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
    Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
    Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial-temporal order-disorder transition in angiogenic NOTCH signaling controls cell fate specification.
    Kang TY; Bocci F; Nie Q; Onuchic JN; Levchenko A
    Elife; 2024 Feb; 12():. PubMed ID: 38376371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.